MedTrace Logo

Postoperative Morbidity and Mortality After Gastric Cancer Surgery

NCT06277908 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2024-02-26

No results posted yet for this study

Summary

Gastric cancer is still one of the main health care issue and gastrectomy with lymph node dissection is the only chance to be cure. Trials show that the postoperative course differs significantly between eastern and western centers, as well as between clinics within Russian Federation. Postoperative 30-day postoperative mortality after gastric cancer surgery ranges from 1% to 5%, and postoperative complication rates range from 10% to 40%. To improve the quality of further studies and recommendations for standardization of surgical treatment of gastric cancer and its complications, there is a need to study the differences in 90-day postoperative morbidity and mortality in different clinics and centers of the Russian Federation.

Conditions

  • Gastric Cancer
  • Siewert Type III Adenocarcinoma of Esophagogastric Junction
  • Stomach Cancer

Interventions

PROCEDURE

Elective Surgery for gastric cancer

Total, distal or proximal gastrectomy via open, laparoscopic or robotic approach

Sponsors & Collaborators

  • National Medical Research Radiological Centre of the Ministry of Health of Russia

    collaborator OTHER

  • P. Herzen Moscow Oncology Research Institute

    lead OTHER_GOV

Principal Investigators

  • Andrey Ryabov, MD, PhD · P.Herzen Moscow Oncological Research Institute

  • Vladimir Khomyakov, MD, PhD · P.Herzen Moscow Oncological Research Institute

  • Nuriddin Abdulkhakimov, MD, PhD · P.Herzen Moscow Oncological Research Institute

  • Pavel Smirnov · P.Herzen Moscow Oncological Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-18
Primary Completion
2024-09-18
Completion
2024-12-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06277908 on ClinicalTrials.gov